Flow cytometric single cell-based assay to simultaneously detect cell death, cell cycling, DNA content and cell

Elizabeth Lieschke1,2, Zilu Wang1,2, Catherine Chang1

  • 1The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.

Insights

This study introduces a novel flow cytometry assay for simultaneously measuring cell death, cell cycle arrest, and cellular senescence. This tool aids in dissecting complex cell fate decisions in various cell types.

Area of Science:

  • Cellular biology
  • Cancer research
  • Molecular oncology

Background:

  • Cell death, cell cycle arrest, and cellular senescence are critical responses to oncogene activation and anti-cancer agents, often involving the tumor suppressor TP53.
  • These cellular processes are not mutually exclusive and can occur concurrently within a cell population or an individual cell.
  • Current assays are limited, often visualizing only one or two responses and potentially missing the dominant outcome.

Purpose of the Study:

  • To develop a novel flow cytometric assay for simultaneous assessment of multiple cellular responses.
  • To enable single-cell level analysis of cell viability, cell cycling, and senescence.
  • To provide a tool for dissecting complex cell fate decisions.

Main Methods:

  • Development of a novel flow cytometry assay.
  • Simultaneous measurement of DNA content (cell cycling) and DNA synthesis.
  • Assessment of senescence markers at the single-cell level.

Main Results:

  • The assay successfully allows for the simultaneous assessment of cell viability, cell cycling, and senescence.
  • Demonstrated applicability to both human and murine cells, including cancerous and non-transformed cell lines.
  • The assay effectively dissects complex cell fate decisions.

Conclusions:

  • The developed flow cytometry assay is a valuable experimental tool for biological research.
  • Enables comprehensive analysis of cellular responses, overcoming limitations of existing methods.
  • Facilitates the study of diverse biological processes, particularly in cancer research and drug development.